Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW.

Blood. 1997 Oct 15;90(8):2901-10.

2.

PLC-gamma activation is required for PDGF-betaR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells.

Alimandi M, Heidaran MA, Gutkind JS, Zhang J, Ellmore N, Valius M, Kazlauskas A, Pierce JH, Li W.

Oncogene. 1997 Jul 31;15(5):585-93.

3.

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP.

Oncogene. 1997 May 8;14(18):2175-88. Erratum in: Oncogene 1997 Dec 4;15(23):2883.

4.
5.

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system.

Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T.

Oncogene. 1997 Jan 30;14(4):439-49.

6.

Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase.

Ueno H, Sasaki K, Kozutsumi H, Miyagawa K, Mitani K, Yazaki Y, Hirai H.

J Biol Chem. 1996 Nov 1;271(44):27707-14.

7.

The control of inositol lipid hydrolysis.

Katan M.

Cancer Surv. 1996;27:199-211. Review.

PMID:
8909802
8.

Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide.

Hall H, Williams EJ, Moore SE, Walsh FS, Prochiantz A, Doherty P.

Curr Biol. 1996 May 1;6(5):580-7.

9.

Cloning and characterization of GRB14, a novel member of the GRB7 gene family.

Daly RJ, Sanderson GM, Janes PW, Sutherland RL.

J Biol Chem. 1996 May 24;271(21):12502-10.

10.

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).

Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4181-6.

13.

Oncogenic activation of tyrosine kinases.

Rodrigues GA, Park M.

Curr Opin Genet Dev. 1994 Feb;4(1):15-24. Review.

PMID:
8193535
14.

Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S.

Oncogene. 1994 Jun;9(6):1567-74.

PMID:
8183550
15.

Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide.

Pascal SM, Singer AU, Gish G, Yamazaki T, Shoelson SE, Pawson T, Kay LE, Forman-Kay JD.

Cell. 1994 May 6;77(3):461-72.

PMID:
8181064
16.

Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about.

Sawyers CL, Denny CT.

Cell. 1994 Apr 22;77(2):171-3. Review. No abstract available.

PMID:
8168126
17.
18.

Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma.

Obermeier A, Bradshaw RA, Seedorf K, Choidas A, Schlessinger J, Ullrich A.

EMBO J. 1994 Apr 1;13(7):1585-90.

19.

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT.

Science. 1994 Mar 4;263(5151):1281-4. Erratum in: Science. 1995 Jan 20;267(5196):316-7.

PMID:
8122112
20.

Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo.

Kozutsumi H, Toyoshima H, Hagiwara K, Yazaki Y, Hirai H.

Oncogene. 1994 Oct;9(10):2991-8.

PMID:
8084603

Supplemental Content

Support Center